Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2007
12/13/2007US20070287826 Production of high molecular mass lectins
12/13/2007US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
12/13/2007US20070286914 having as its major glycosyl components glucose, galactose, mannose and arabinose
12/13/2007US20070286849 Treatment of autoimmune disorders
12/13/2007CA2657946A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease
12/13/2007CA2654784A1 Substituted phenylacetic acids as dp-2 antagonists
12/13/2007CA2654623A1 An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease
12/13/2007CA2653424A1 Novel indazole derivative having spiro ring structure in side chain
12/12/2007EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/12/2007EP1865058A1 Anti-cd-20 monoclonal antibody
12/12/2007EP1865055A1 Component of bromelain
12/12/2007EP1864992A2 Monosaccharide derivatives
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1864675A1 Orally administered peptides to ameliorate atherosclerosis
12/12/2007EP1864665A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
12/12/2007EP1864659A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
12/12/2007EP1863842A2 High affinity hiv t cell receptors
12/12/2007EP1863794A2 Pyrimidine compounds and methods of use
12/12/2007EP1863787A1 Hydogrenated benzo[c]thiophene derivatives as immunomodulators
12/12/2007EP1863785A1 Novel thiophene sulfoximines for treating cmplement-mediated deseases and conditions
12/12/2007EP1863498A2 Composition comprising isoorientin for suppressing histamine
12/12/2007EP1863480A1 Compounds having immunomodulator activity
12/12/2007EP1863474A1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
12/12/2007EP1532250B1 Fcyriia transgenic animal model for autoimmune disease
12/12/2007EP1309618B1 Leucine-based motif and clostridial neurotoxins
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007EP1255456B1 Use of glutamate or of glutamic acid for the prevention of hyperpermeability or undesired permeability of the intestinal wall
12/12/2007EP1237912B1 Five-helix protein
12/12/2007EP1161254B1 Treatment of autoimmune diseases with american ginseng extract
12/12/2007EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals
12/12/2007EP1144454B1 Modified peptides as therapeutic agents
12/12/2007EP1137792B9 A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/12/2007EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use
12/12/2007EP0871434B2 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
12/12/2007EP0819123B1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
12/12/2007EP0769967B1 Conjugates comprising an antitumour agent and their use
12/12/2007CN101085813A Soluble TNF acceptor mutant
12/12/2007CN101085802A Method for preparing Notoginsen triterpenes
12/12/2007CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/12/2007CN101085349A Vesicle guiding immunocyte and application of the same in preparing antineoplastic medicine
12/12/2007CN101085341A Eye implanted gel containing cyclosporin
12/12/2007CN101085239A Internal-applied traditional Chinese medicinal composition for treating allergic purpura
12/12/2007CN101084969A Method for preparing compound traditional Chinese medicine preparation containing barrenwort
12/12/2007CN101084952A Method for preparing extraction of acanthopanax senticousus saponins
12/12/2007CN101084945A Olive leaves extraction and preparation method thereof
12/12/2007CN101084941A Abelmoschus manihot health care soft opaque capsule
12/12/2007CN101084939A Abelmoschus manihot health care hard capsule
12/12/2007CN101084936A Method for preparing ginkgo leaves extraction
12/12/2007CN101084934A Liquid capsule of lucidum spore oil and preparation method
12/12/2007CN101084933A Medicinal composition for strengthening immunity and its preparing process
12/12/2007CN101084923A Method for preparing rabbit against human T lymphocytes immune serum
12/12/2007CN101084910A Glucocorticoid synergist
12/12/2007CN101084889A Ginkgolide freezing-dried powder injection and preparation method thereof
12/12/2007CN100354282C Thienopyridazinones and their use in modulation of autoimmune disease
12/12/2007CN100354000C Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
12/12/2007CA2577762A1 Ccr5 antagonist for enhancing immune reconstitution and treating opportunistic infection in hiv patients
12/11/2007US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity
12/11/2007US7307081 Treatment of Human Immunodeficiency Virus, organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
12/11/2007US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide
12/11/2007US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools.
12/11/2007US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis
12/11/2007US7306782 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
12/11/2007CA2413510C Condensed pyrazindione derivatives
12/11/2007CA2348735C Heterocyclic potassium channel inhibitors
12/06/2007WO2007139948A2 Imidazoazepinone compounds
12/06/2007WO2007139921A2 N-oxides of kappa opioid receptor peptides
12/06/2007WO2007139833A2 Imidazoazephinone compounds
12/06/2007WO2007139795A1 Thiophene-carboxamides useful as inhibitors of protein kinases
12/06/2007WO2007139499A1 Compounds for use as a medicament
12/06/2007WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof
12/06/2007WO2007139211A1 Process for production of optically active piperidine compound
12/06/2007WO2007139190A1 Immunostimulatory oligonucleotide and pharmaceutical application thereof
12/06/2007WO2007139164A1 Humanized anti-human osteopontin antibody
12/06/2007WO2007138994A1 Hsp90 inhibitor
12/06/2007WO2007138993A1 Method for culture of lactic acid bacterium having high immunomodulating activity
12/06/2007WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor
12/06/2007WO2007138905A1 Intestinal eosinophil-suppressing composition
12/06/2007WO2007138311A1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
12/06/2007WO2007138135A1 Bioadhesive nanoparticles for administration of biologically active molecules
12/06/2007WO2007137984A2 Modified humanised anti-interleukin-18 antibodies
12/06/2007WO2007107828A3 Amine derivatives
12/06/2007WO2007104715A3 Specific cd4+cd25+ regulatory t cells for haematopoietic cell transplantation and immune tolerance
12/06/2007WO2007091919A8 Method for treating chronic illnesses (variants), method for producing a biograft (variants) and a biograft (variants)
12/06/2007WO2007062245A3 Human monoclonal antibody human cd134 (ox40) and methods of making and using same
12/06/2007WO2007055773A3 Use of inhibitors of pi3k-c2a for the treatment of apoptos i s-related disorders
12/06/2007WO2003023001A3 Novel proteins and nucleic acids encoding same
12/06/2007US20070282105 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
12/06/2007US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007US20070281960 Anti-Histaminic Composition
12/06/2007US20070281956 Phenylpyrimidine amines as IgE inhibitors
12/06/2007US20070281944 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/06/2007US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands
12/06/2007US20070281897 By administering a cyclic di-GMP or a cyclic dinucleotide analogue; use as vaccine adjuvant
12/06/2007US20070280975 Method for Producing Maca Extract
12/06/2007US20070280971 Phosphodiesterase type IV (PDE4) inhibitor; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; inflammatory and/or allergic diseases such as atopic dermatitis
12/06/2007US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases
12/06/2007US20070280954 Novel Immunomodulating Peptide
12/06/2007US20070280951 Cell Death Inducing Agents
12/06/2007US20070280930 Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury
1 ... 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 ... 1172